Clinical Trial Update: Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers [Phase 3]

View source ↗

Summary

Phase 3 study evaluating incidence of gastric ulcers with PA32540 (aspirin + omeprazole) versus enteric-coated aspirin 325 mg in at-risk individuals; study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Ulcer

Drugs mentioned

• Enteric-coated aspirin 325 mg (aspirin (acetylsalicylic acid), enteric-coated)
• PA32540 (aspirin/omeprazole)

Snippet

Sponsor: POZEN | Conditions: Gastric Ulcer | Phase 3 | Status: COMPLETED | Results posted: 2016-02-17